168 related articles for article (PubMed ID: 9572061)
41. Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation.
Boomsma F; Hut H; Bagghoe U; van der Houwen A; van den Meiracker A
Med Sci Monit; 2005 Apr; 11(4):RA122-6. PubMed ID: 15795708
[TBL] [Abstract][Full Text] [Related]
42. Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in Type 2 diabetes mellitus.
Grönvall-Nordquist JL; Bäcklund LB; Garpenstrand H; Ekblom J; Landin B; Yu PH; Oreland L; Rosenqvist U
J Diabetes Complications; 2001; 15(5):250-6. PubMed ID: 11522499
[TBL] [Abstract][Full Text] [Related]
43. Semicarbazide-sensitive amine oxidase substrates potentiate hydralazine hypotension: possible role of hydrogen peroxide.
Vidrio H; Medina M; González-Romo P; Lorenzana-Jiménez M; Díaz-Arista P; Baeza A
J Pharmacol Exp Ther; 2003 Nov; 307(2):497-504. PubMed ID: 12970383
[TBL] [Abstract][Full Text] [Related]
44. Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do.
O'Sullivan J; Unzeta M; Healy J; O'Sullivan MI; Davey G; Tipton KF
Neurotoxicology; 2004 Jan; 25(1-2):303-15. PubMed ID: 14697905
[TBL] [Abstract][Full Text] [Related]
45. Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury.
Yu PH; Zuo DM
Atherosclerosis; 1996 Feb; 120(1-2):189-97. PubMed ID: 8645360
[TBL] [Abstract][Full Text] [Related]
46. Semicarbazide-sensitive amine oxidase (SSAO) gene expression in alloxan-induced diabetes in mice.
Nordquist JE; Göktürk C; Oreland L
Mol Med; 2002 Dec; 8(12):824-9. PubMed ID: 12606817
[TBL] [Abstract][Full Text] [Related]
47. Changes in the activities of semicarbazide-sensitive amine oxidase in inferior mesenteric artery segments and in serum of patients with type 2 diabetes.
Nunes SF; Figueiredo IV; Pereira JS; Soares PJ; Caramona MM; Callingham B
Acta Diabetol; 2010 Jun; 47(2):179-82. PubMed ID: 20063021
[TBL] [Abstract][Full Text] [Related]
48. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
Stolen CM; Madanat R; Marti L; Kari S; Yegutkin GG; Sariola H; Zorzano A; Jalkanen S
FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
[TBL] [Abstract][Full Text] [Related]
49. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride.
Mészáros Z; Szombathy T; Raimondi L; Karádi I; Romics L; Magyar K
Metabolism; 1999 Jan; 48(1):113-7. PubMed ID: 9920154
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
Wang SH; Yu TY; Hung CS; Yang CY; Lin MS; Su CY; Chen YL; Kao HL; Chuang LM; Tsai FC; Li HY
Sci Rep; 2018 Jun; 8(1):9249. PubMed ID: 29915377
[TBL] [Abstract][Full Text] [Related]
51. Plasma semicarbazide-sensitive amine oxidase in stroke.
Garpenstrand H; Ekblom J; von Arbin M; Oreland L; Murray V
Eur Neurol; 1999 Jan; 41(1):20-3. PubMed ID: 9885324
[TBL] [Abstract][Full Text] [Related]
52. Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology.
Boomsma F; Bhaggoe UM; van der Houwen AM; van den Meiracker AH
Biochim Biophys Acta; 2003 Apr; 1647(1-2):48-54. PubMed ID: 12686107
[TBL] [Abstract][Full Text] [Related]
53. Semicarbazide-sensitive amine oxidase in transgenic mice with diabetes.
Gokturk C; Nordquist J; Sugimoto H; Forsberg-Nilsson K; Nilsson J; Oreland L
Biochem Biophys Res Commun; 2004 Dec; 325(3):1013-20. PubMed ID: 15541390
[TBL] [Abstract][Full Text] [Related]
54. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia.
Yu PH
Med Hypotheses; 2001 Aug; 57(2):175-9. PubMed ID: 11461168
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus.
Valente T; Gella A; Solé M; Durany N; Unzeta M
J Neurosci Res; 2012 Oct; 90(10):1989-96. PubMed ID: 22714978
[TBL] [Abstract][Full Text] [Related]
56. Alterations in plasma semicarbazide-sensitive amine oxidase activity in hypertensive heart disease with left ventricular systolic dysfunction.
Marinho C; Arduíno D; Falcão LM; Bicho M
Rev Port Cardiol; 2010 Jan; 29(1):37-47. PubMed ID: 20391898
[TBL] [Abstract][Full Text] [Related]
57. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin.
Boomsma F; Derkx FH; van den Meiracker AH; Man in 't Veld AJ; Schalekamp MA
Clin Sci (Lond); 1995 Jun; 88(6):675-9. PubMed ID: 7634751
[TBL] [Abstract][Full Text] [Related]
58. Deamination of methylamine and aminoacetone increases aldehydes and oxidative stress in rats.
Deng Y; Boomsma F; Yu PH
Life Sci; 1998; 63(23):2049-58. PubMed ID: 9839528
[TBL] [Abstract][Full Text] [Related]
59. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
[TBL] [Abstract][Full Text] [Related]
60. Vasoactive effects of methylamine in isolated human blood vessels: role of semicarbazide-sensitive amine oxidase, formaldehyde, and hydrogen peroxide.
Conklin DJ; Cowley HR; Wiechmann RJ; Johnson GH; Trent MB; Boor PJ
Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H667-76. PubMed ID: 14715500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
